Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Celgene Corporation to Webcast at Two Upcoming Investor Conferences and the American Academy of Dermatology Annual Meeting



  Celgene Corporation to Webcast at Two Upcoming Investor Conferences and the
  American Academy of Dermatology Annual Meeting

Business Wire

SUMMIT, N.J. -- February 28, 2013

Celgene Corporation (NASDAQ: CELG) plans to present at two upcoming investor
conferences. The conferences will be webcast live and will be available in the
Investor Relations section of the Company’s Web site at www.celgene.com.
Celgene management will provide an overview of the Company.

Tuesday, March 5, 2013 Celgene will present at the Cowen and Company 33rd
Annual Health Care Conference at 11:20 a.m. ET.

Thursday, March 14, 2013 Celgene will present at the Barclays Global
Healthcare Conference at 8:30 a.m. ET.

Celgene will also  host a webcast of an investor event at the American Academy
of Dermatology Annual Meeting on Sunday, March 3 at 6:00 p.m. ET. Members of
Celgene’s management team and clinical investigators will discuss the ESTEEM-1
results in moderate-to-severe psoriasis. The meeting will be webcast live and
will be available in the Investor Relations section of the Company’s web site
at www.celgene.com.

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated
global biopharmaceutical company engaged primarily in the discovery,
development and commercialization of novel therapies for the treatment of
cancer and inflammatory diseases through gene and protein regulation. For more
information, please visit the company’s Web site at www.celgene.com.

Forward-Looking Statements

This press release contains forward-looking statements, which are generally
statements that are not historical facts. Forward-looking statements can be
identified by the words "expects," "anticipates," "believes," "intends,"
"estimates," "plans," "will," “outlook” and similar expressions.
Forward-looking statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are made. We
undertake no obligation to update any forward-looking statement in light of
new information or future events, except as otherwise required by law.
Forward-looking statements involve inherent risks and uncertainties, most of
which are difficult to predict and are generally beyond our control. Actual
results or outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of factors,
many of which are discussed in more detail in our Annual Report on Form 10-K
and our other reports filed with the Securities and Exchange Commission.

Contact:

Celgene
Jacqualyn A. Fouse, Ph.D
EVP, Chief Financial Officer
908-673-9956
Patrick E. Flanigan III
VP, Investor Relations
908-673-9969
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement